Table 3.
Pain Medication Use among Patients with SCD (N = 3368)
| Pain Medication Use | SCD Patients (N = 3368) | |
|---|---|---|
| N | % | |
| Opioid and Nonopioid pain medication | ||
| Pain medication use (all): mean±SD, claims | 5.2 ± 7.9 | |
| Yes | 2217 | 65.8 |
| No | 1151 | 34.2 |
| Opioid Medication | ||
| Opioid use: mean±SD, claims | 4.2 ± 7.2 | |
| Yes | 1978 | 58.7 |
| No | 1390 | 41.3 |
| 1–5 | 1210 | 35.9 |
| 6–10 | 313 | 9.3 |
| 11–15 | 191 | 5.7 |
| 16–20 | 112 | 3.3 |
| >20 | 152 | 4.5 |
| Nonopioid Medication | ||
| Nonopioid pain medication use: mean±SD, claims | 1.1 ± 2.1 | |
| Yes | 1243 | 36.9 |
| No | 2125 | 63.1 |
| Nonsteroidal anti-inflammatory drugs | 1173 | 34.8 |
| Acetaminophen | 136 | 4.0 |
| Others (butalbital + acetaminophen + caffeine) | 42 | 1.3 |
Abbreviations: SCD, sickle cell disease; VOC, vaso-occlusive crisis; SD, standard deviation.